Phase III Safety Evaluation of Cyclosporine 0.1% Ophthalmic Emulsion Administered Twice Daily to Dry Eye Disease Patients for Up to 3 Years

Authors:
  • SPStephen C. Pflugfelder
    Stephen C. Pflugfelder
  • JTJoseph Tauber
    Joseph Tauber
  • GFGary N. Foulks
    Gary N. Foulks

Abstract
No abstract available

This publication has 15 references indexed in Scilit: